Inhibition of STAT3 activation by ALT through S-glutathionylation has revealed an unprecedented mechanism and provided in-depth insight into molecular mechanism of ALT in the treatment of A549 lung adenocarcinoma cells as a single agent or in combination with clinical drugs suffering from drug resistance due to induction of STAT3 activation. The gene discussed is GPT; the disease is lung adenocarcinoma.